Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company · Abingdon

IG Innovations Limited

Research and experimental development on biotechnology

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is IG Innovations Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 13

  1. Kenneth James Rowe 2020-2022 Director View profile
  2. Paolo Beato 2018-2020 Director View profile
  3. Brian Bernard Yoor 2017-2018 Director View profile
  4. Nicholas Anthony Breare 2017-2022 Director View profile
  5. Neil Edward James 2015-2018 Director View profile
  6. John Bridgen 2014-2017 Director View profile
  7. Joseph Patrick Mcnamara 2014-2016 Director View profile
  8. Dr James Soares 2014-2018 Director View profile
  9. Stewart Wilson 2014-2017 Director View profile
  10. Dr Christopher Williams 2010-2017 Director View profile
  11. Dr David Scott 2010-2014 Director View profile
  12. Mark James Davis 2010-2014 Director View profile
  13. Professor Paul James Davis 2010-2014 Director View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

What it does
Research and experimental development on biotechnology
Incorporated
12/03/2010
Registered office
Abingdon

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. IG Innovations Limited is controlled by Abbott Toxicology Limited
    Evidence
    active 75-100% shares · notified 2016-04-06 · source: Companies House PSC register
  2. Abbott Toxicology Limited is controlled by Alere UK Holdings Limited
    Evidence
    active 75-100% shares · notified 2016-04-06 · source: Companies House PSC register

Ultimately controlled by Alere UK Holdings Limited.

15 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

3 directors on the board

4.2y median 4.2y
average tenure
4.5y
longest tenure
0
directors past 6 years

First-time vs portfolio directors

Portfolio (3)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Finance 9Health and social care 6Manufacturing 6Professional services 5Retail and trade 3Business services 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
07188244
Status
Active
Type
Private Limited Company
Accounts next due
30/09/2027
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data